BioPetroClean, a Petah Tikva, Israel-based cleantech start-up specializing in biological wastewater treatment, recently announced the signing of an agreement with The Dow Chemical Company. Under a global commercial agreement, Dow will market the Dow BPC Water Treatment system to refinery and produced-water markets with exclusivity in various regions.
BioPetroClean’s Automated Chemostat Treatment (BPC-ACT) is an innovative approach to wastewater treatment, consisting of three elements: a bacteria cocktail customized for specific water types, a control unit, and a basin or tank that serves as the reactor. According to the Company, BioPetroClean's bioremediation solutions allow a wastewater treatment plant to increase its reliability and capacity while reducing cost of operations.
“The selection of the BPC solution by a worldwide leader such as Dow is a great endorsement from a company that can help us take advantage of the worldwide opportunity and enable massive deployment of our new and exciting technology,” said David Amir, CEO of BioPetroClean.
“Dow BPC Water Treatment technology has immense potential — for communities, the oil and gas industry, the environment and our business,” said Janet Giesselman, President and General Manager of Dow Oil & Gas. “We are committed to creating clean, sustainable water supplies. This is one more step toward solving this global challenge.”
Dow and BPC are working on a first field application of the Dow-BPC Water Treatment system.
BioPetroClean's investors include 21Ventures, a New York-based venture capital fund. BioPetroClean reportedly raised between $5 million and $8.5 million from 21Ventures and Quercus Trust in 2008.
BioPetroClean raises funds from 21Ventures
Israel boasts 6 water startups, including Emefcy and AquaPure, in Artemis Project list